CRISPR/Cas9 genome editing technology was used to generate a truncating deletion of sequences downstream of the second Tudor domain of the encoded protein. This line has only Tudor domain 3 removed. Histone array analysis demonstrated that the truncated protein has severely diminished histone-binding capacity.